Chinese Pharmaceutical Giant Acquires Stake in Vietnamese Drugmaker: A Trend of Foreign Dominance
Diplomacy

Chinese Pharmaceutical Giant Acquires Stake in Vietnamese Drugmaker: A Trend of Foreign Dominance

China's Livzon Pharmaceutical Group has acquired a 67.87% stake in Vietnam's Imexpharm, marking a significant move in the local pharmaceutical sector. This follows a broader trend of foreign firms from Japan, the U.S., and Germany taking control of or forming strategic alliances with leading Vietnamese drugmakers.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.